CAM
WVE icon

Cresset Asset Management’s Wave Life Sciences WVE Stock Holding History

Cresset Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.2K Sell
13,799
-581
-4% -$3.85K ﹤0.01% 1679
2026
Q1 		$104K Sell
14,380
-3,549
-20% -$46.2K ﹤0.01% 1540
2025
Q4 		$305K Buy
17,929
+2,905
+19% +$29.5K ﹤0.01% 1292
2025
Q3 		$110K Buy
+15,024
New +$122K ﹤0.01% 1489

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Cresset Asset Management's WVE Position: Q2 2026 in Review

Cresset Asset Management reduced its Wave Life Sciences (WVE) stake by 4% in Q2 2026, selling an estimated $3.85K and leaving 13,799 shares worth $80.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

Cresset Asset Management first reported a position in WVE in Q3 2025 and has held it in 4 quarters since. The position peaked at $305K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Cresset Asset Management held 13,799 shares of Wave Life Sciences worth $80.2K as of Q2 2026.
  • Cresset Asset Management sold 581 Wave Life Sciences shares in Q2 2026, an estimated $3.85K.
  • Wave Life Sciences made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1679 holding.
  • Cresset Asset Management first reported a position in Wave Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • Cresset Asset Management's Wave Life Sciences position peaked at $305K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.